KRAS and neoplasm: Herein, the objectives of this study were: (1) to further validate the ARMS–HRMA technique for detecting the most common four types of mutations in codon 12 of KRAS in tumor and plasma samples from a larger cohort of PDAC patients and (2) to evaluate its usefulness in predicting disease progression and overall mortality.